Boca Raton Mass Torts Attorneys Keep up With the Latest Complications and Warnings Related to Transvaginal Mesh Surgeries
Helping injury victims recover the compensation they deserve for more than five decades
Over the past ten to twenty years, transvaginal mesh surgeries have become more prevalent. Used to treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI), surgical mesh is supposed to relieve patients of painful medical conditions and symptoms. Instead, transvaginal mesh has been proven to lead to significant complications that have impacted thousands of women. The skilled personal injury attorneys at Osborne & Francis Law Firm PLLC are committed to helping clients recover compensation for lost wages, emotional distress and medical expenses incurred by a defective mesh product, hospital negligence or physician errors.
Transvaginal mesh products have the potential to cause serious and debilitating complications
Medical conditions such as POP and SUI are caused by a weakening of the muscles and tissues that support pelvic muscles. Transvaginal mesh is designed to strengthen the pelvic floor and support these muscles. However, thousands of patients have experienced serious complications after transvaginal mesh implantation that has led to the need for several additional corrective procedures and outrageous medical bills. Complications of transvaginal mesh include:
• Erosion or protrusion of the mesh from the soft tissues
• Pain, including pain during intercourse
• Infections in the area of the mesh
• Urinary tract problems
• Bleeding from the mesh site
• Damage to nearby organs such as perforation
These complications lead to months and even years of additional recovery time and interfere with a victim’s personal and professional life.
Warnings about transvaginal mesh complications illustrate the dangers of such procedures
The first transvaginal mesh product was introduced into the market by Boston Scientific in 1996. By 1999, that product was recalled due to more than 100 complaints from patients of pain, infection and tissue damage. The Food and Drug Administration (FDA) has monitored transvaginal mesh and issued several warnings about the risks associated with its use.
• October 20, 2008 – The FDA issues a Public Health Notification and Additional Patient Information on the serious complications stemming from the use of transvaginal mesh. At this time, there were more than 1,000 reports of adverse events during 2005-2007 associated with transvaginal mesh.
• July 30, 2011 – The FDA issues an update to its previous warning to advise the public that complications from transvaginal mesh used to treat POP are not rare and may expose patients to greater risk.
• September 2011 – The FDA’s Obstetrics and Gynecology Devices Panel recommends reclassifying transvaginal mesh devices for POP from a Class II low-to-moderate risk device to a Class III high risk device. Manufacturers must also seek Pre-Market Approval.
• January 2012 – The FDA orders 522 post-market studies to examine the safety and efficacy of transvaginal mesh.
• April 29, 2014 – The FDA issues two proposed orders to address the health risks associated with transvaginal mesh in the setting of POP.
While these warnings are designed to warn and educate both the general public and medical community, transvaginal mesh procedures are still very common, as are the risks and complications that go along with surgical mesh.
Experienced Florida personal injury attorneys are ready to advise you of your legal rights and options following an unsuccessful transvaginal mesh procedure
The serious complications that many people experience following surgical mesh implantation are emotionally, physically and financially debilitating. At Osborne & Francis Law Firm PLLC, our personal injury attorneys understand the personal nature of these types of cases and strive to provide a high level of legal representation in a compassionate and sensitive environment. To schedule a free consultation, call 561-293-2600 or contact us online today.